Vimarsana
Biggest News Aggregation in the World

Cognitive Difficulties News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cognitive Difficulties. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cognitive Difficulties Today - Breaking & Trending Today

Mental health problems come with an added 'cost' of poorer cognitive function – a neuropsychologist explains - Vimarsana News

Mental health problems come with an added 'cost' of poorer cognitive function – a neuropsychologist explains

While only about 20% of people would qualify for a formal diagnosis of a mental disorder, more than 60% express symptoms of those disorders – and those symptoms can lead to cognitive difficulties.

Source: yahoo.com
Exploring the Impact of COVID-19 on the Brain and Body - Vimarsana News

Exploring the Impact of COVID-19 on the Brain and Body

COVID-19 patients who reported cognitive difficulties were more likely to experience long-term physical symptoms.

One in 10 older adults in U.S. has dementia: research-Xinhua - Vimarsana News

One in 10 older adults in U.S. has dementia: research-Xinhua

One in 10 older adults in U.S. has dementia: research-

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society - Vimarsana News

Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International...

Alkermes plc: Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society - Vimarsana News

Alkermes plc: Alkermes Presents New Data From Psychiatry Portfolio at 2022 Congress of the Schizophrenia International Research Society

- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented